Crucell N.V. Shareholders Approve Exchange Offer For Berna Biotech AG
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that the General Meeting of Shareholders has approved the exchange offer for Berna Biotech A.G. (Swiss Exchange: BBIN) in accordance with Section 2:107a of the Dutch Civil Code.